Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Applied Biotechnology Institute (ABI) is a biotechnology company specializing in the production of high-value recombinant proteins using a proprietary plant-based expression platform, primarily in maize. Founded by Dr. John Howard, a pioneer in molecular farming, the company develops animal-free alternatives for widely used proteins such as trypsin (TrypZean), avidin, and aprotinin, serving the pharmaceutical, research, and industrial markets. Beyond its commercial protein portfolio, ABI is advancing a pipeline of oral vaccines and therapeutic proteins for both human and animal health. By leveraging its scalable and cost-effective plant-based technology, the company aims to provide safe biological products that eliminate the risks associated with animal-derived contaminants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Applied Biotechnology.